Journal Mobile Options
Table of Contents
Vol. 50, No. 1, 2004
Issue release date: January–February 2004
Gerontology 2004;50:39–43

MMSE Cross-Domain Variability Predicts Cognitive Decline in Centenarians

Kliegel M. · Sliwinski M.
aInstitute of Psychology, Department of Gerontopsychology, University of Zurich, Zurich, Switzerland; bDepartment of Psychology, Syracuse University, Syracuse, N.Y., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Early detection of dementia is one of the key issues in cognitive gerontology. However, so far the detection of early stages in cognitive decline has been rather unreliable. One central limitation of current assessment strategies is that they rely on information about a person’s level of performance obtained from a single assessment. Objective: In the first part of the present paper, we propose three strategies for overcoming this limitation by using information from several measurement occasions to improve diagnostic reliability. Methods: In the second part, we present one exemplary empirical analysis of one of these approaches reporting data from the Heidelberg Centenarian Study. Results: In this sample of very old individuals tested at baseline and at a follow-up 18 months later, the intra-individual cross-domain variability across MMSE subscales [1]at baseline predicted cognitive decline (i.e. change in an external cognitive functioning rating from baseline to follow-up) much better than baseline mean MMSE scores. Conclusions: In conclusion, we discuss the advantage of performance varibility as a predictor for cognitive decline.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Folstein MF, Folstein SE, McHugh PR: Mini-Mental-State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  2. Buschke H, Sliwinski M, Kuslansky G, Lipton R: Diagnosis of early dementia by the Double Memory Test: Encoding Specificity improves diagnostic sensitivity and specificity. Neurology 1997;48:989–997.
  3. Buschke H, Kuslansky G, Katz M, Stewart WF, Sliwinski M, Eckholdt HM, Lipton RB: Screening for dementia with the memory impairment screen (MIS). Neurology 1999;50:231–238.
  4. Darby D, Maruff P, Collie A, McStephen M: Mild cognitive impairment can be detected by multiple assessments in a single day. Neurology 2002;59:1042–1046.
  5. Collie A, Maruff P, Currie J: Behavioral characterization of mild cognitive impairment. J Clin Exp Neuropsychol 2002;24:720–733.

    External Resources

  6. Hultsch DF, MacDonald SWS, Hunter MA, Levy-Bencheton J, Strauss E: Intraindividual variability in cognitive performance in older adults: Comparison of adults with mild dementia, adults with arthritis, and healthy adults. Neuropsychology 2000;14:588–598.
  7. Knotek PC, Bayles KA, Kaszniak AW: Response consistency on a semantic memory task in persons with dementia of the Alzheimer type. Brain Language 1990;38:465–475.
  8. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303–308.
  9. Bischkopf J, Busse A, Angermeyer MC: Mild cognitive impairment: A review of prevalence, incidence and outcome according to current approaches. Acta Psychiatr Scand 2002;106:403–414.
  10. Nesselroade JR: The warp and woof of the developmental fabric; in Downs R, Liben L, Palermo DS (eds): Visions of Aesthetics, the Environment, and Development: The Legacy of Joachim F. Wohwill. Hillsdale, Erlbaum, 1991, pp 213–240.
  11. Burns A, Zaudig M: Mild cognitive impairment in older adults. Lancet 2002;360:1963–1965.
  12. Sliwinski M, Hofer S, Hall CB, Buschke H, Lipton R: Modeling memory decline in older adults: The importance of preclinical dementia, attrition and chronological age. Psych Aging, in press.
  13. Strauss E, MacDonald, SWS, Hunter M, Moll A, Hultsch DF: Intraindividual variability in cognitive performance in three age groups of older adults: Cross-domain links to physical status and self-perceived affect and beliefs. J Int Neuropsychol Soc 2002;8:893–906.
  14. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Bäckman L: The course of cognitive impairment in preclinical Alzheimer disease: Three- and 6-year follow-up of a population-based sample. Arch Neurol 2000;57:839–844.
  15. Rott C, d’Heureuse V, Kliegel M, Schönemann P, Becker G: The Heidelberg Centenarian Study: Theoretical and methodological foundations of psychosocial research in the oldest old. Z Gerontol Geriatr 2001;34:356–364.
  16. Andersen-Ranberg K, Vasegaard L, Jeune B: Dementia is not inevitable: A population-based study of Danish centenarians. J Gerontol Psychol Sci 2001;56B:152–159.
  17. Holtsberg PA, Poon LW, Noble CA, Martin P: Mini-mental state exam status of community-dwelling cognitively intact centenarians. Int Psychogeriatr 1995;7:417–427.
  18. Reisberg B, Ferris SH, deLeon MJ, Crook T: The Global Deterioration Scale (GDS) for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136–1139.
  19. Overall J, Scott J, Rhodes H, Lesser J: Empirical scaling of the stages of cognitive decline in senile dementia. J Geriatric Psychiatry Neurol 1990;3:212–220.
  20. Reisberg B, et al: Overview of methodologic issues for pharmacologic trials in mild, moderate and severe Alzheimer’s disease. Int Psychogeriatr 1996;8:159–193.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50